Keryx Biopharmaceuticals (KERX)
$2.38
0.00 (+0.04%)
| CAPS Rating |
|
|---|---|
| Open | $2.31 |
| Previous Close | $2.38 |
| Daily Range | $2.25 - $2.40 |
| 52-Week Range | $0.09 - $3.33 |
| Market Cap | $133.23M |
| P/E Ratio | 8.81 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 677,548 |
| Average Daily Volume | 848,000 |
How do you think KERX will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
KERX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
KERX News and Commentary
- One Bet You're Sure to Lose – The Motley Fool
- Tomorrow's Monster Stock? – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
- 6 Stocks Attracting Top Investors – The Motley Fool
- 9 Stocks Shaking the Market – The Motley Fool
- These Stocks Can Easily Double Your Money – The Motley Fool
- 5 Stocks Bouncing Back – The Motley Fool
- These 5 Underdogs Are No Dogs – The Motley Fool
- UPDATE 1-Keryx kidney drug shows positive long-term data – Reuters
- 10 Stocks Shaking the Market – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- UPDATE 1-Keryx cancer drug gets orphan drug status; shares soar – Reuters
- Francorp – Blog at The Motley Fool
- A New Era at AEterna – The Motley Fool
Related News and Articles
- This Big Winner Has Hit Its Prime – The Motley Fool
- Dream Stocks for Biotech Investors – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool


RSS Headlines
Fool UK